{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-068511","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.686992+00:00","generated_at":"2026-06-18T04:43:06.784370+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"ALX Oncology says SVB exposure immaterial; loan facility with SVB under review","bullets":["Uninsured cash at SVB is less than 0.8% of total cash equivalents and investments.","Majority of cash in segregated custody at U.S. Bank via SAM; SVB has no claim.","Has up to $100M secured term loan; SVB funded 50%; assessing options for SVB's position."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-068511","json":"https://secwatch.observer/filing/0001193125-23-068511.json","markdown":"https://secwatch.observer/filing/0001193125-23-068511.md","text":"https://secwatch.observer/filing/0001193125-23-068511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/0001193125-23-068511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312523068511/d456798d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:43:06.784370+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}